Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Moscow Exchange is developing a bookbuilding system

12/8/23 MOEX

Novatek may first send gas via the Northern Sea Route in January-April

12/8/23 NVTK

Nornickel shareholders approve share split

12/7/23 GMKN

VTB will return to dividend payments no earlier than 2026

12/7/23 VTBR

Shareholders of Nornickel approved dividends

12/7/23 GMKN

Globaltrans CFO leaves Globaltrans

12/7/23 GLTR

TMK to place 40 mln additional shares

12/7/23 TRMK

Moscow Exchange conducted the first deal with DFA on the secondary market

12/7/23 MOEX

Abrau-Durso launches a new project in Moscow - Abrau Club

12/7/23 ABRD

Etalon renews sales record

12/7/23 ETLN